Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

13.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccine strategies for cancer prevention in Lynch syndrome: the potential of dendritic cell-based therapy.

Familial cancer·2026
Same author

Cytotoxic CD4+ T cells in cancer: an emerging target for next-generation anticancer immunotherapy?

Journal for immunotherapy of cancer·2025
Same author

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.

BMJ open·2025
Same author

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Research square·2025
Same author

NEOadjuvant Dendritic cell therapy added to first line standard of care in advanced epithelial Ovarian Cancer (NEODOC): protocol of a first-in-human, exploratory, single-centre phase I/II trial in the Netherlands.

BMJ open·2025
Same author

Interleukin-6 in synovial fluid drives the conversion of DC2s to DC3s in inflammatory arthritis.

iScience·2025

Related Experiment Video

Updated: Apr 30, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.9K

Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.

Ghaith Bakdash1, Inge Schreurs, Gerty Schreibelt

  • 1Department of Tumor Immunology, Radboud University Medical Centre and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

Expert Review of Clinical Immunology
|April 25, 2014
PubMed
Summary

This review explores the interactions between myeloid dendritic cells (DCs) and plasmacytoid DCs, highlighting their combined potential in DC-based immunotherapy for infectious diseases and cancer.

Keywords:
cancercrosstalkimmunotherapymyeloid DCsplasmacytoid DCs

More Related Videos

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.1K
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

17.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.9K
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.1K
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

17.7K

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Dendritic cells (DCs) are crucial for initiating immune responses.
  • Two main DC subsets, myeloid and plasmacytoid, exist in peripheral blood.
  • Interactions between DCs and other immune cells are well-studied, but DC subset crosstalk is less explored.

Purpose of the Study:

  • To review existing literature on crosstalk between myeloid and plasmacytoid DCs.
  • To elucidate the mechanisms of action in DC subset interactions.
  • To highlight the therapeutic potential of combined DC subsets in immunotherapy.

Main Methods:

  • Comprehensive literature review of studies on DC subset crosstalk.
  • Analysis of phenotypic and functional characteristics of myeloid and plasmacytoid DCs.
  • Evaluation of potential therapeutic strategies involving DC combinations.

Main Results:

  • Identified limited research on crosstalk among different DC subsets.
  • Highlighted the distinct roles and potential synergistic interactions of myeloid and plasmacytoid DCs.
  • Underscored the significance of DC subset crosstalk in infectious diseases and cancer.

Conclusions:

  • DC subset crosstalk, particularly between myeloid and plasmacytoid DCs, is vital for effective immune responses.
  • Understanding these interactions can lead to novel DC-based immunotherapy strategies.
  • Further research into DC-DC communication is warranted for advancing cancer and infectious disease treatments.